PDT Study for Exudative AMD With PCV

Inclusion Criteria: * Japanese patients aged 50 years old or older * Exudative AMD with subfoveal PCV * Eyes with PCV meets the definite criteria of PCV issued from Japanese study group of Polypoidal Choroidal Vasculopathy * PCV lesion with subfoveal hemorrhage or exudation * Lesion size (GLD) of less than 12 MPS Disc area measured by FA and IA. * Decimal BCVA of 0.1-0.5 at baseline period. Exclusion Criteria: * Patients who have RPE tear, vitelliform retinal dystrophy, and central Serous Chorioretinopathy. * Patients who have other ocular disease with irreversible VA * Study eyes unable to be taken fundus photos of CNV * Study eyes received surgery operation within 2 months of the participation to this study or ND:YAG operation within one month * Pathological myopia * PCV with cleary identified subsensory retinal CNV (on the RPE) at the baseline examination * Study eyes which have received any treatments for CNV, such as PDT, transpupillary thermotherapy, laser photocoagulation, and so on. * Patients who have any physical problem for using angiography or PDT (such as systemic debility, significant diabetes mellitus, significant heart disease, and so on) * Medical history of porphyria, porphyrin sensitivity, or hypersensitivity to sunlight or bright light. * Patients with medical history of hypersensitivity to ingredients of Visudyne * Patients with medical history of hypersensitivity to ingredients of fluorescein or indocyanine green injection * Patients with hypersensitivity to iodine * Patients judged inappropriate for this study by the investigator